JNK in inflammation and lipid metabolism regulation in atherosclerosis

Dan Tang1, Yi Yao2, Xing Xiang1

  • 1Department of Clinical Laboratory Medicine, Institution of microbiology and infectious diseases, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China; Hunan Provincial Key Laboratory of Multi-omics And Artificial Intelligence of Cardiovascular Diseases, University of South China, Hengyang, Hunan, China; Clinical Research Center for Myocardial Injury in Hunan Province, Hengyang, Hunan, China; Institute of Cardiovascular Disease, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

PubMed

Insights

Atherosclerosis involves complex regulation, with c-Jun N-terminal kinase (JNK) central to its development. Targeting JNK may offer new treatments for this systemic arterial disease.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Pathophysiology

Background:

  • Atherosclerosis is a systemic arterial disease marked by lipid buildup, inflammation, and endothelial dysfunction.
  • Complex, multifactorial regulation drives atherosclerosis pathogenesis.
  • c-Jun N-terminal kinase (JNK), a stress-activated kinase, is implicated in disease development.

Purpose of the Study:

  • To review the role of JNK in atherosclerosis.
  • To highlight JNK as a potential therapeutic target for atherosclerosis.

Main Methods:

  • This is a review article, synthesizing existing research on JNK's role in atherosclerosis.
  • Literature review focusing on molecular mechanisms and interorgan effects.

Main Results:

  • JNK regulates key pathogenic processes including oxidative stress, lipid metabolism, and inflammation.
  • Vascular injury activates JNK, amplifying inflammation and disease progression.
  • JNK influences vascular health via metabolic and inflammatory pathways in organs like the liver and kidneys.

Conclusions:

  • JNK plays a central role in the pathogenesis of atherosclerosis.
  • Targeting JNK pathways presents a promising therapeutic strategy for atherosclerosis.
  • Understanding JNK's interorgan effects is crucial for developing effective treatments.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
Inflammation01:38

Inflammation

Overview
55.1K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
686